Group One Trading
TRIL

Group One Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Group One Trading’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-534,200
Closed -$9.38M – 9205
2021
Q3 		$9.38M Buy
534,200
+472,400
+764% +$5.52M 0.01% 1111
2021
Q2 		$599K Sell
61,800
-21,600
-26% -$203K ﹤0.01% 4021
2021
Q1 		$896K Sell
83,400
-123,800
-60% -$1.53M ﹤0.01% 3366
2020
Q4 		$3.05M Buy
207,200
+154,100
+290% +$2.22M 0.01% 1685
2020
Q3 		$755K Buy
53,100
+26,000
+96% +$259K ﹤0.01% 2457
2020
Q2 		$219K Buy
27,100
+14,400
+113% +$89.1K ﹤0.01% 3301
2020
Q1 		$51K Buy
+12,700
New +$48K ﹤0.01% 3710
2018
Q4 		– Sell
-2,000
Closed -$12K – 5651
2018
Q3 		$12K Hold
2,000
– – ﹤0.01% 4608
2018
Q2 		$12K Hold
2,000
– – ﹤0.01% 4565
2018
Q1 		$14K Buy
+2,000
New +$15.2K ﹤0.01% 4218

Other funds holding TRIL

Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Group One Trading's TRIL Position: Q4 2021 in Review

Group One Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 331,989 shares — an estimated $5.83M sold.

Group One Trading first reported a position in TRIL in Q1 2018 and held it in 10 quarters. The position peaked at $5.83M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

  • Group One Trading reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
  • Group One Trading sold 331,989 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $5.83M.
  • Group One Trading first reported a position in Trillium Therapeutics Inc. in Q1 2018 and held it in 10 quarters.
  • Group One Trading's Trillium Therapeutics Inc. position peaked at $5.83M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.